Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,372 | 29 | 65.2% |
| Consulting Fee | $11,093 | 5 | 13.8% |
| Travel and Lodging | $9,512 | 26 | 11.8% |
| Food and Beverage | $7,339 | 329 | 9.1% |
| Education | $64.36 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $38,420 | 47 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $34,281 | 43 | $0 (2024) |
| ARGENX US, INC. | $1,367 | 11 | $0 (2024) |
| ABBVIE INC. | $1,132 | 82 | $0 (2024) |
| Akcea Therapeutics, Inc. | $1,077 | 3 | $0 (2021) |
| MDD US Operations, LLC | $422.97 | 4 | $0 (2024) |
| PFIZER INC. | $397.09 | 47 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $345.80 | 18 | $0 (2024) |
| Biogen, Inc. | $309.16 | 14 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $255.46 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,416 | 172 | Alnylam Pharmaceuticals Inc. ($8,323) |
| 2023 | $14,188 | 138 | Alnylam Pharmaceuticals Inc. ($7,879) |
| 2022 | $12,320 | 21 | Alexion Pharmaceuticals, Inc. ($6,215) |
| 2021 | $12,403 | 19 | Alnylam Pharmaceuticals Inc. ($7,218) |
| 2020 | $5,605 | 3 | Alnylam Pharmaceuticals Inc. ($4,675) |
| 2019 | $22,932 | 30 | Alexion Pharmaceuticals, Inc. ($22,633) |
| 2018 | $225.58 | 3 | Daiichi Sankyo Inc. ($145.97) |
| 2017 | $290.15 | 5 | Mitsubishi Tanabe Pharma America, Inc. ($132.57) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Immunology and Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: PAIN | ||||||
| 12/12/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Ultragenyx Pharmaceutical Inc. | Dojolvi (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Oral nutritional supplements | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: PAIN | ||||||
| 11/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 414 | 572 | $232,711 | $56,087 |
| 2022 | 8 | 520 | 823 | $183,101 | $84,340 |
| 2021 | 9 | 620 | 981 | $223,443 | $108,289 |
| 2020 | 13 | 505 | 629 | $161,902 | $59,124 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 218 | $83,196 | $20,730 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $37,488 | $8,512 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 69 | $36,785 | $8,179 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $27,682 | $6,857 | 24.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 59 | 115 | $24,276 | $6,084 | 25.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 25 | 25 | $10,016 | $2,579 | 25.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 12 | 12 | $8,948 | $2,122 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $4,320 | $1,024 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 397 | $75,430 | $35,043 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 94 | 151 | $38,958 | $19,845 | 50.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 73 | 138 | $21,390 | $10,910 | 51.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $14,994 | $5,801 | 38.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 25 | 25 | $13,125 | $5,430 | 41.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 35 | 35 | $12,250 | $4,581 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,535 | $1,980 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,419 | $750.18 | 52.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 404 | $76,760 | $38,885 | 50.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 89 | 155 | $39,990 | $21,400 | 53.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 88 | 162 | $25,110 | $13,168 | 52.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 91 | $26,754 | $11,611 | 43.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 57 | 57 | $21,033 | $8,166 | 38.8% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 33 | 33 | $17,325 | $8,029 | 46.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 40 | 40 | $14,000 | $5,789 | 41.4% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 17 | 17 | $1,921 | $899.81 | 46.8% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 11 | 22 | $550.00 | $340.56 | 61.9% |
About Dr. John Eatman, M.D
Dr. John Eatman, M.D is a Neurology healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2011. The National Provider Identifier (NPI) number assigned to this provider is 1942596523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Eatman, M.D has received a total of $80,380 in payments from pharmaceutical and medical device companies, with $12,416 received in 2024. These payments were reported across 391 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,372).
As a Medicare-enrolled provider, Eatman has provided services to 2,059 Medicare beneficiaries, totaling 3,005 services with total Medicare billing of $307,839. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location North Kansas City, MO
- Active Since 06/22/2011
- Last Updated 07/16/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1942596523
Products in Payments
- SOLIRIS (Drug) $22,633
- AMVUTTRA (Drug) $14,912
- ONPATTRO (Drug) $11,742
- ULTOMIRIS (Biological) $8,874
- Soliris (Drug) $3,099
- VYVGART (Drug) $1,226
- SOLIRIS (Biological) $636.22
- QULIPTA (Drug) $545.87
- NURTEC ODT (Drug) $397.09
- Apokyn (Drug) $381.91
- NUPLAZID (Drug) $345.80
- UBRELVY (Drug) $343.42
- TYSABRI (Biological) $177.01
- RYTARY (Drug) $147.15
- Morphabond ER (Drug) $145.97
- ZEPOSIA (Drug) $140.97
- Ocrevus (Biological) $139.93
- Radicava (Drug) $132.57
- VYVGART HYTRULO (Drug) $128.79
- WAINUA (Drug) $126.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in North Kansas City
Dr. Steven Kosa, Md, MD
Neurology — Payments: $337,461
Larry Hollenbeck, Md, MD
Neurology — Payments: $15,794
Dr. Cynthia Costa, Md, MD
Neurology — Payments: $9,988
Dr. Shannon Kohake, Md, MD
Neurology — Payments: $6,090
Fred Sachen, Md, MD
Neurology — Payments: $125.90
Robert Satake, Md, MD
Neurology — Payments: $34.35